InhaleRx Limited (AU:IRX) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
InhaleRx Limited has announced a significant change in the director’s interests, with Director James Barrie acquiring 492,792 fully paid ordinary shares in lieu of accrued director fees, valued at $16,500. This move reflects the company’s ongoing adjustments in its governance and financial strategies.
For further insights into AU:IRX stock, check out TipRanks’ Stock Analysis page.